ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ)
$29.24 -0.08 (-0.2729%)
Analysed ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) News Sources
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
09-04-2026
yahoo.com
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates
19-03-2026
yahoo.com
Assembly Biosciences: Q4 Earnings Snapshot
19-03-2026
yahoo.com
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
19-03-2026
yahoo.com
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
05-03-2026
yahoo.com
Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates
26-02-2026
yahoo.com
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
25-02-2026
yahoo.com
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors
24-12-2025
yahoo.com
GILD Exercises Option to License Assembly Bio's Herpes Programs
23-12-2025
yahoo.com
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
22-12-2025
yahoo.com
What is the current price of ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ)?
The current price of ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) is $29.24.
ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) since the previous trading day is $-0.08.
ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) since the previous trading day is -0.2729%.
What is the most recent average sentiment score for ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ)?
The most recent average sentiment score for ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ)?
The most recent sentiment for ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ) is .
SEC-8K** Filing Available For ASSEMBLY BIOSCIENCES INC (ASMB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.